Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07893912Phase 1Enrolling by invitation
Phase 1, open-label, single-arm trial of ayahuasca, sponsored by Universidade de São Paulo. Primary endpoint: Regional cerebral glucose metabolic rate at 4 hours. Started Oct 2026; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07893912.